LAHORE, MAY 2019: CCL’s flagship brand, SITA Met (SITA and SITA Met franchises) has hit the one billion sales milestone, according to the March, 2019 IMS MAT report. SITA Met is already a market leader in the Sitagliptin category since long and is used with a proper diet and exercise program and possibly with other medications to control high blood sugar.
“I would like to thank the entire CCL team for helping us to achieve this major milestone as we express our commitment to passionately serving the communities around the globe,” said Muhammad Akram, Commercial Director, CCL.
“SITA is a vital part of CCL’s family of innovative products, which has been established through a decade of hard work and team collaboration of marketing and sales teams,” remarks Rizwan ur Rasheed, Marketing Manager of cardio-metabolic teams.
Excited Syed Muhammad Abdullah, Business Manager, Pharma said “We are glad that this SITA Met brand is making such a huge impact on patients. Through excellent quality and effectiveness, SITA Met range of products is winning the trust of patients to help them feel better.”.
He said that with a passion to grow Acer team’ Sultans did a tremendous job in executing ‘dare to dream’ vision in a very professional manner, driving an accelerated execution of innovative strategies and tactics. “Each team member exercised his or her pivotal role by winning collaboration hence achieving this historical landmark and proved themselves real ‘maidan key Sultan,” he added.
Syed Muhammad Abdullah further added that the Acer team has the ambition to improve their community service by doubling the SITA Met sales value in the next three years.
This milestone will be celebrated soon by the Pharma team, they will reach out to all CCL colleagues in the Head Office and regional offices and will announce the milestone and express their gratitude.
